Fenway Health is pleased to announce the appointment of four new members to its Board of Directors for fiscal year 2021. Each new member brings a wealth of experience, insight, and community building knowledge as Fenway Health continues to grow and meet the challenges of the COVID-19 age.
“I look forward to partnering with Amy, Colin, Guadalupe, and Vincent in the upcoming year,” said Board Chair Jonathan Matsui, PhD. “These new Board members bring diverse talents, knowledge, and lived experience to our organization. Their individual and collective counsel and expertise will significantly strengthen our already dynamic board.”
“Our Board is comprised of community members dedicated to ensuring access to the highest quality health care, education, and research. This year and beyond, our Board will continue working tirelessly to strengthen Fenway’s commitment to enhancing the wellbeing of LGBTQIA+ people and all those we serve,” he added.
The Board of Directors supports the work of Fenway Health and provides mission-based leadership and governance. Board members provide essential resources to fulfill our mission, help us break down barriers to health equity, and guide the future of Fenway Health.
Let us introduce you to our newest Board members:
Colin Gibbons, MHA
Colin currently works in the Corporate Strategy and M&A practice at Philips Healthcare, a Dutch multinational conglomerate focused on medical technology and devices. Colin works on high-impact strategic topics and conducts business development activities across Philips’ diverse business lines.
He previously worked as a Senior Consultant at PricewaterhouseCoopers in their Health Systems Strategy and Operations practice. There, he developed strategic plans and identified growth opportunities for health systems across the country.
Colin holds a BS in Microbiology from Brandeis University and a Master of Healthcare Administration from Columbia University, as well as executive certificates from the MIT Sloan School of Business and the Healthcare Financial Management Association.
Guadalupe Hayes-Mota, MBA, MS, MPP
Guadalupe is a healthcare leader with over 10 years of transforming regional and global organizations in pharmaceuticals, biotech, hospitals, and policy. Guadalupe is the Director of Global Supply Chain and Manufacturing at Ultragenyx Pharmaceuticals, where he leads the worldwide production and distribution of the company’s gene therapy medicines and supplies to 35 countries.
Previously, he directed the global production and distribution of medicines to 93 countries at biotech firms (Biogen & GSK). Guadalupe also ran 12 free healthcare clinics for underserved-populations in Los Angeles Metropolitan Area (UCLA Health) and helped to develop and implement the Affordable Care Act as a policy analyst (RAND Corporation).
Guadalupe holds a BS, MS in Engineering, and an MBA from MIT, and a Masters of Public Policy from Georgetown University.
Amy Rasimas, MBA
Amy is a strategic and financial leader in corporate treasury, operational management and risk. As Treasurer of Axcelis Technologies, Inc., she oversees banking relationships, investments, capital structure, and risk management.
Amy holds a BA from Colby College and a MBA from Simmons College.
Vincent C. Smith, MD, MPH
Vincent is Division Chief of Newborn Medicine at Boston Medical Center (BMC) and Associate Professor of Pediatrics at Boston University Medical School. In addition to parental NICU discharge readiness, his professional interests also include families affected by substance use and medical care for LGBTQ-headed families.
Vincent is a graduate of Texas A&M University, Stanford University School of Medicine, and the Harvard School of Public Health. He trained in pediatrics at Boston Children’s Hospital (BCH) and BMC in the Boston Combined Pediatric Residency Program. He has completed a fellowship in neonatal-perinatal medicine and a fellowship in health services research.